COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge

Willa Cochran; Sonsoles Salto-Alejandre; Lindsay Barker; Julie Langlee; Kristin Freed; Debra Carter; Jaclyn Bannon; Dillon Goddard; Heba Mostafa; William Werbel; Pali Shah; Dorry Segev; Daniel Brennan; Robin Avery

doi:10.1097/TP.0000000000004418

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge

Willa Cochran, Sonsoles Salto-Alejandre, Lindsay Barker, Julie Langlee, Kristin Freed, Debra Carter, Jaclyn Bannon, Dillon Goddard, Heba Mostafa, William Werbel, Pali Shah, Dorry Segev, Daniel Brennan, Robin Avery

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E60-E61
Journal	Transplantation
Volume	107
Issue number	2
DOIs	https://doi.org/10.1097/TP.0000000000004418
State	Published - Feb 1 2023

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/TP.0000000000004418

Cite this

Cochran, W., Salto-Alejandre, S., Barker, L., Langlee, J., Freed, K., Carter, D., Bannon, J., Goddard, D., Mostafa, H., Werbel, W., Shah, P., Segev, D., Brennan, D., & Avery, R. (2023). COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge. Transplantation, 107(2), E60-E61. https://doi.org/10.1097/TP.0000000000004418

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge. / Cochran, Willa; Salto-Alejandre, Sonsoles; Barker, Lindsay et al.
In: Transplantation, Vol. 107, No. 2, 01.02.2023, p. E60-E61.

Research output: Contribution to journal › Letter › peer-review

Cochran, W, Salto-Alejandre, S, Barker, L, Langlee, J, Freed, K, Carter, D, Bannon, J, Goddard, D, Mostafa, H , Werbel, W , Shah, P, Segev, D, Brennan, D & Avery, R 2023, 'COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge', Transplantation, vol. 107, no. 2, pp. E60-E61. https://doi.org/10.1097/TP.0000000000004418

@article{f35a52f656d442ebbed0b4905419a67f,

title = "COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge",

author = "Willa Cochran and Sonsoles Salto-Alejandre and Lindsay Barker and Julie Langlee and Kristin Freed and Debra Carter and Jaclyn Bannon and Dillon Goddard and Heba Mostafa and William Werbel and Pali Shah and Dorry Segev and Daniel Brennan and Robin Avery",

note = "Funding Information: Research reported in this publication was performed as a project of the Immune Tolerance Network and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health under award number UM1AI109565. ",

year = "2023",

month = feb,

day = "1",

doi = "10.1097/TP.0000000000004418",

language = "English (US)",

volume = "107",

pages = "E60--E61",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge

AU - Cochran, Willa

AU - Salto-Alejandre, Sonsoles

AU - Barker, Lindsay

AU - Langlee, Julie

AU - Freed, Kristin

AU - Carter, Debra

AU - Bannon, Jaclyn

AU - Goddard, Dillon

AU - Mostafa, Heba

AU - Werbel, William

AU - Shah, Pali

AU - Segev, Dorry

AU - Brennan, Daniel

AU - Avery, Robin

N1 - Funding Information: Research reported in this publication was performed as a project of the Immune Tolerance Network and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health under award number UM1AI109565.

PY - 2023/2/1

Y1 - 2023/2/1

UR - http://www.scopus.com/inward/record.url?scp=85146771611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146771611&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000004418

DO - 10.1097/TP.0000000000004418

M3 - Letter

C2 - 36228295

AN - SCOPUS:85146771611

SN - 0041-1337

VL - 107

SP - E60-E61

JO - Transplantation

JF - Transplantation

IS - 2

ER -

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this